Evaluation of efficacy and side effects of chitosan alginate dressings in chronic wound heal

Evaluation of efficacy and side effects of chitosan alginate dressings in chronic wound heal in patients refer to shohadaye tajrish hospital during two years

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016041927480N1

Enrollment

Registered

2017-01-07

Start date

2016-09-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic ulcer. Chronic ulcer of skin, not elsewhere classified

Interventions

Intervention 1: 32 patients are enrolled in our trial randomely assigned to two groups each has 16 patients first treated with chitosan-alginate dressing . Intervention 2: Second group consist of 16 p

Treatment - Other

Treatment - Drugs

32 patients are enrolled in our trial randomely assigned to two groups each has 16 patients first treated with chitosan-alginate dressing .

Second group consist of 16 patients treated with convensional dressings that is silver sulfadiazine in this study

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age more than 18 years old; chronic wound with duration more than 4-6 weeks; wound diameter 1-200 square centimeter; consent for entering trial. Exclusion criteria: refuse to enroll; allergy to shellfish, lobster; attending other trials; pregnancy; lactation; severe co-morbidity; collagen vascular ulcers or severe infected ulcers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
For chronic ulcer assessment of remission. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0-24...no improvement,25-49:...moderate improvement,50-74:significant improvement.....75-100:complete improvement.;Degree of erythema. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0: no erythema,1:pink,2:red.;Degree of exudate. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0:no 1:low 2: moderate-severe.;Degree of odor. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0:negative 1:positive.;Patient satisfaction. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: Low noderate good excellent.	—

Measure

Time frame

For chronic ulcer assessment of remission. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0-24...no improvement,25-49:...moderate improvement,50-74:significant improvement.....75-100:complete improvement.;Degree of erythema. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0: no erythema,1:pink,2:red.;Degree of exudate. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0:no 1:low 2: moderate-severe.;Degree of odor. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: 0:negative 1:positive.;Patient satisfaction. Timepoint: Visit and photo taking each 2-3 days. Method of measurement: Low noderate good excellent.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Yasaman Ketabi

Shohadaye Tajrish Hospital

yac_kt@yahoo.com+98 21 2229 2895

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026